Skip to main content
    E

    eXoZymes, Inc. (EXOZ)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $3.92
    +0.09 (+2.35%)

    Market Cap: $35.64M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    eXoZymes, Inc. (EXOZ) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to eXoZymes are Biomea Fusion (BMEA), XBiotech (XBIT) and EyePoint (EYPT). By market cap, eXoZymes ranks 7th of the 13 companies on this page; XBiotech (XBIT) is the largest at $59.76M.

    Peer Comparison

    EXOZ's ROIC of -455.6% is below the peer median of -28.6%, and its revenue growth of 0.0% is in line with the median. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    eXoZymes (EXOZ)$35.64MN/AN/A0.0%-455.6%0.0%0.00%
    Biomea Fusion Inc (BMEA)$42.31MN/AN/A0.0%N/A0.0%0.00%
    XBiotech Inc (XBIT)$59.76MN/AN/A0.0%N/A-93.3%0.00%
    EyePoint, Inc (EYPT)$34.82MN/A10.6x0.0%N/A-21.7%0.00%
    iBio, Inc. Common Stock (IBIO)$51.55MN/A735.4x0.0%N/A975.0%0.00%
    Elicio Therapeutics Inc. (ELTX)$42.46MN/AN/A0.0%-96.6%0.0%0.00%
    Quince Therapeutics, Inc. (QNCX)$32.27MN/AN/A0.0%N/A0.0%0.00%
    Hyperion DeFi, Inc. (HYPD)$39.84MN/A20.3x474.9%22.2%1560.0%0.00%
    RenovoRx Inc (RNXT)$50.18MN/A16.6x0.0%N/A300.8%0.00%
    Edesa Biotech Inc (EDSA)$26.21MN/AN/A0.0%N/A-99.9%0.00%
    OS Therapies Incorporated (OSTX)$34.87MN/AN/A0.0%218.0%0.0%0.00%
    Evaxion Biotech AS (EVAX)$25.27MN/A0.2x-115.5%-79.5%-100.0%0.00%
    Context Therapeutics Inc (CNTX)$16.61MN/AN/A0.0%N/A0.0%0.00%
    Peer median$37.36MN/A16.6x0.0%-28.6%0.0%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to eXoZymes, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    Biomea Fusion Inc (BMEA)
    Biomea Fusion, Inc., a biopharmaceutical company, is focused on the discovery, development and commercialization of irreversible small molecules to treat...
    BMEA competitors
    XBiotech Inc (XBIT)
    XBiotech Inc., a biopharmaceutical company, discovers, develops and markets True Human monoclonal antibodies for the treatment of various diseases.
    XBIT competitors
    EyePoint, Inc (EYPT)
    EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and markets ophthalmic products for the treatment of eye diseases in the United States...
    EYPT competitors
    iBio, Inc. Common Stock (IBIO)
    iBio, Inc., a biotech company, provides contract development and manufacturing services to outside partners and customers in the United States.
    IBIO competitors
    Elicio Therapeutics Inc. (ELTX)
    Elicio Therapeutics Inc. (ELTX) is a clinical-stage biotechnology company specializing in innovative immunotherapies for cancer treatment.
    ELTX competitors
    Quince Therapeutics, Inc. (QNCX)
    Quince Therapeutics, Inc., a biopharmaceutical company, is focused on advancing precision therapies for rare and debilitating diseases.
    Hyperion DeFi, Inc. (HYPD)
    Hyperion DeFi, Inc., an ophthalmic technology company, engages in development and commercialization of ophthalmic solutions in the United States.
    HYPD competitors
    RenovoRx Inc (RNXT)
    RenovoRx, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for the treatment of solid tumors.
    RNXT competitors
    Edesa Biotech Inc (EDSA)
    Edesa Biotech, Inc., a clinical-stage biopharmaceutical company, is engaged in the research and development...
    EDSA competitors
    OS Therapies Incorporated (OSTX)
    OS Therapies Incorporated is a pioneering biopharmaceutical company committed to developing innovative treatments for unmet medical needs...
    OSTX competitors
    Evaxion Biotech AS (EVAX)
    Evaxion Biotech A / S, a clinical-stage artificial intelligence and immunology platform company...
    EVAX competitors
    Context Therapeutics Inc (CNTX)
    Centrexion Therapeutics Corporation, a late-stage biopharmaceutical company, focuses on identifying, developing, and commercializing novel, non-opioid...
    CNTX competitors

    Frequently Asked Questions About EXOZ

    Who are eXoZymes' main competitors?

    The companies most similar to eXoZymes include Biomea Fusion (BMEA), XBiotech (XBIT), EyePoint (EYPT), iBio, Inc. Common Stock (IBIO) and Elicio Therapeutics (ELTX), listed from the closest match.

    Who is eXoZymes' biggest competitor?

    XBiotech (XBIT) is the largest of the similar companies at $59.76M; Biomea Fusion (BMEA) is the closest match by business profile, size, sector and industry.

    How does EXOZ stock compare with its competitors?

    EXOZ's net margin is 0.0% against a peer median of 0.0%.

    Which of eXoZymes' competitors pays a higher dividend?

    eXoZymes pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is eXoZymes bigger than its competitors?

    No. eXoZymes is 7th by market cap among the 13 companies on this page; the largest is XBiotech (XBIT) at $59.76M.